Browse Studies — Arctuva

Observational

QAIAx (AIhealth4U) - AI Smart Health Cities: Microcity Enclave Program (UPSTO App No(s). 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428) is Frontier AI/AGI Public Health Trials Sandbox Framework That Provides Free Public Health Services to Registered and Sponsored Visitors/Occupants for RDT&E Under 28 U.S.C. 1498 (Classified as a PPA, OTA Under 10 U.S. Code 4001, 4022), Serving as a Global Intranet of Humans Resident Patients Among Multiple Enclave Communicates ("AI Microcities" or "Smart Health Cities") Living and Learning With AI Robotics for Non-medicinal Treatment.

BRIEF SUMMARY A. "What is the purpose of this study?" BACKGROUND. The QAIAx clinical trial (Quantum AI/AGI Public Health Agency), known operationally as the …

Asperger's DisorderAsperger DisorderAutism Disorder+41 more

Estimated

~$10 – $5,625

Veterans Recovery Network Inc.NCT07661823

Phase 2

GLP-1R Agonist Treatment for Opioid Use Disorder

The goal of this clinical trial is to learn if semaglutide can reduce illicit opioid use in adults in outpatient treatment for opioid use disorder, and who are…

Opioid Use DisorderOpioid Abuse and AddictionNarcotic-Related Disorders+4 more

Estimated

~$10 – $6,250

Milton S. Hershey Medical CenterNCT06548490

Phase 3

Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits

The primary aim of this implementation-effectiveness trial is to examine the effectiveness of Mindfulness-Oriented Recovery Enhancement (MORE) and patient-cent…

Chronic PainPrescription Opioid MisuseSubstance-Related Disorders+6 more

Estimated

~$10 – $6,250

University of UtahNCT06387290